Cart
sales@molnova.com
Tiplaxtinin
CAS No. 393105-53-8
Tiplaxtinin( PAI-039 )
Catalog No. M14351 CAS No. 393105-53-8
Tiplaxtinin(PAI-039) is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 33 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 78 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 246 | In Stock |
|
| 100MG | 484 | In Stock |
|
| 500MG | 1035 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTiplaxtinin
-
NoteResearch use only, not for human use.
-
Brief DescriptionTiplaxtinin(PAI-039) is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 uM.
-
DescriptionTiplaxtinin(PAI-039) is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 uM.
-
In Vitro——
-
In Vivo——
-
SynonymsPAI-039
-
PathwayMetabolic Enzyme/Protease
-
TargetPAI-1
-
RecptorPAI-1
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number393105-53-8
-
Formula Weight439.38
-
Molecular FormulaC24H16F3NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(O)C(C1=CN(CC2=CC=CC=C2)C3=C1C=C(C4=CC=C(OC(F)(F)F)C=C4)C=C3)=O
-
Chemical Name2-(1-benzyl-5-(4-(trifluoromethoxy)phenyl)-1H-indol-3-yl)-2-oxoacetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Elokdah H, et al. J Med Chem. 2004 Jul 1;47(14):3491-4.
molnova catalog
related products
-
XR 5118
XR 5118 is a small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor with IC50 of 3.5 uM.
-
Angstrom6
Angstrom6 (A-6 peptide) is an 8 amino acid peptide derived from single chain urokinase fibrinogen activator (scuPA) that interferes with the uPA/uPAR cascade and abrogates the downstream effects.
-
Aleplasinin
Aleplasinin is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Aleplasinin can be used in Alzheimer's disease studies.
